Tempus

Tempus has raised $1.05 billion in total funding, including a $200 million Series G round in December 2020 at an $8.1 billion valuation, backed by Google, Novo Holdings, Baillie Gifford, Franklin Templeton Investments, and T. Rowe Price. In October 2022, the company secured additional financing through an undisclosed Series G extension and a conventional debt facility to support continued growth. These investments have strengthened Tempus’s AI-driven precision medicine platform, expanding its genomic sequencing capabilities, clinical data infrastructure, and decision-support tools for oncologists, hospitals, and life sciences partners.